인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
피인용 0
초록·키워드
In our ongoing research for anti-Helicobacter pylori compounds from natural resources, the methanol extract of Carpinus tschonoskii Maxim. (Betulaceae), Asian hornbeam, distributed in eastern Asia showed significant anti-Helicobacter pylori activity. Five fractions of n-hexane, CH₂Cl₂, EtOAc, n-BuOH, and aqueous fractions were obtained from the MeOH extract of C. tschonoskii leaves, and tested against H. pylori strains 51 and 26695. The EtOAc fraction, demonstrating superior inhibitory activity, was subjected to further chromatography, leading to the isolation of four flavonols, namely isoquercetin (1), quercitrin (2), afzelin (3), and kaempferol (4), and a hydroquinone (5). The chemical structures of these compounds were elucidated using UV, ¹H-NMR, <sup>13</sup>C-NMR, and mass spectrometry. Among these isolates, compounds 4 and 5 displayed significant growth inhibition on H. pylori at a final concentration of 100 μM. While compound 4 showed anti-H. pylori activity against both the tested strains 51 and 26695 with MIC<sub>50</sub> values of 63.6 μM and 55.1 μM, respectively, the values of compound 5 were more than 100 μM for the two strains. Structurally, compound 3, with a rhamnose moiety at the oxygen atom of the C-3 position of compound 4, failed to exhibit a significant inhibitory capability. Molecular docking studies predicted that compound 4 interactions occur at αTyr32, αVal33, βPhe441, and βLys445 of H. pylori urease 1E9Y. The five isolated compounds, except compound 3, are novel reports of isolation from this plant. Moreover, compound 1 is isolated first from the genus Carpinus. These findings suggest that the EtOAc fraction of C. tschonoskii leaves or kaempferol may be useful candidates for eradicating H. pylori infection. Further studies are required to elucidate the exact mechanism of action and their efficacy on the human body with safety issues.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-151-26-02-094377629
